MedPath

Effect of yoga and physical exercises on Telomere length in Diabetes mellitus

Not Applicable
Conditions
Health Condition 1: E119- Type 2 diabetes mellitus without complications
Registration Number
CTRI/2020/09/027695
Lead Sponsor
Department of Science and Technology
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Diagnosis of diabetes in accordance with American Diabetic

Association criteria (fasting plasma glucose >=126mg/dl (>=7.0 mmol/L)

OR 2hr Plasma Glucose >=200mg/dl (11.1mmol/L) OR HbA1C >= 6.5%

(48mmol/mol) OR Random plasma glucose >=200mg/dl (11.1mmol/L)

American Diabetes Association 2016

2. Diagnosed condition of DM2 for 1 to 3 years

3. Subjects on stable glycemic medication for past 3 months

4. Ability and willingness to give consent and comply with study

Exclusion Criteria

1. Subjects with previously diagnosed cardiovascular disease

(hypertension, hyperlipidemia, Obesity (>30 wt/metre 2 ), Coronary

artery disease, heart failure)

2. Subjects with pregnancy, neurological disorders and cancer

3. Acute and chronic inflammation caused by diseases other than

T2DM such as COPD

4. Subjects with history of smoking and alcohol

5. Subjects on exercise intervention, dietary programs or regimens in

the last 3 months

6. Subjects with musculoskeletal conditions impairing the

performance of any physical activity

7. Subjects with known type 1 diabetes mellitus

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
eukocyte Telomere LengthTimepoint: Baseline, 3 months and 6 months
Secondary Outcome Measures
NameTimeMethod
HbA1CTimepoint: Baseline, 3 months and 6 months;MalondialdehydeTimepoint: Baseline, 3 months and 6 months;Super Oxide DismutaseTimepoint: Baseline, 3 months and 6 months
© Copyright 2025. All Rights Reserved by MedPath